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STUDY QUESTION: Does cellular composition of the endometrial biopsy affect the gene expression profile of endometrial whole-tissue samples?
SUMMARY ANSWER: The differences in epithelial and stromal cell proportions in endometrial biopsies modify the whole-tissue gene
expression profiles and affect the results of differential expression analyses.
WHAT IS ALREADY KNOWN: Each cell type has its unique gene expression profile. The proportions of epithelial and stromal cells vary
in endometrial tissue during the menstrual cycle, along with individual and technical variation due to the method and tools used to obtain the
tissue biopsy.
STUDY DESIGN, SIZE, DURATION: Using cell-population specific transcriptome data and computational deconvolution approach, we
estimated the epithelial and stromal cell proportions in whole-tissue biopsies taken during early secretory and mid-secretory phases. The esti-
mated cellular proportions were used as covariates in whole-tissue differential gene expression analysis. Endometrial transcriptomes before
and after deconvolution were compared and analysed in biological context.
PARTICIPANTS/MATERIAL, SETTING, METHODS: Paired early- and mid-secretory endometrial biopsies were obtained from 35
healthy, regularly cycling, fertile volunteers, aged 23–36 years, and analysed by RNA sequencing. Differential gene expression analysis was
performed using two approaches. In one of them, computational deconvolution was applied as an intermediate step to adjust for the propor-
tions of epithelial and stromal cells in the endometrial biopsy. The results were then compared to conventional differential expression ana-
lysis. Ten paired endometrial samples were analysed with qPCR to validate the results.
MAIN RESULTS AND THE ROLE OF CHANCE: The estimated average proportions of stromal and epithelial cells in early secretory
phase were 65% and 35%, and during mid-secretory phase, 46% and 54%, respectively, correlating well with the results of histological evalu-
ation (r = 0.88, P = 1.1 × 10−6). Endometrial tissue transcriptomic analysis showed that approximately 26% of transcripts (n = 946) differen-
tially expressed in receptive endometrium in cell-type unadjusted analysis also remain differentially expressed after adjustment for biopsy
cellular composition. However, the other 74% (n = 2645) become statistically non-significant after adjustment for biopsy cellular composition,
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underlining the impact of tissue heterogeneity on differential expression analysis. The results suggest new mechanisms involved in endometrial
maturation, involving genes like LINC01320, SLC8A1 and GGTA1P, described for the first time in context of endometrial receptivity.
LARGE-SCALE DATA: The RNA-seq data presented in this study is deposited in the Gene Expression Omnibus database with accession
number GSE98386.
LIMITATIONS REASONS FOR CAUTION: Only dominant endometrial cell types were considered in gene expression profile deconvo-
lution; however, other less frequent endometrial cell types also contribute to the whole-tissue gene expression profile.
WIDER IMPLICATIONS OF THE FINDINGS: The better understanding of molecular processes during transition from pre-receptive to
receptive endometrium serves to improve the effectiveness and personalization of assisted reproduction protocols. Biopsy cellular compos-
ition should be taken into account in future endometrial ‘omics’ studies, where tissue heterogeneity could potentially influence the results.
STUDY FUNDING/COMPETING INTEREST(S): This study was funded by: Estonian Ministry of Education and Research (grant IUT34-16);
Enterprise Estonia (EU48695); the EU-FP7 Eurostars program (NOTED, EU41564); the EU-FP7 Marie Curie Industry-Academia Partnerships and
Pathways (SARM, EU324509); Horizon 2020 innovation program (WIDENLIFE, EU692065); MSCA-RISE-2015 project MOMENDO (No 691058) and
the Miguel Servet Program Type I of Instituto de Salud Carlos III (CP13/00038); Spanish Ministry of Economy, Industry and Competitiveness (MINECO)
and European Regional Development Fund (FEDER): grants RYC-2016-21199 and ENDORE SAF2017-87526. Authors confirm no competing interests.
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Introduction
The endometrium is a unique self-renewing tissue that undergoes his-
tologically and functionally distinguished phases of growth and differen-
tiation during the menstrual cycle. This is necessary to synchronize the
endometrium with oocyte maturation, fertilization and embryo
implantation, which takes place in the mid-secretory phase of men-
strual cycle, corresponding to the window of implantation (WOI)
(Harper, 1992). To understand and characterize the receptive pheno-
type of endometrium, initially a histological dating method was devel-
oped (Noyes et al., 1975). With ‘omics’ technologies, the understanding
of molecular processes behind endometrial receptivity has evolved rap-
idly (Altmäe et al., 2014). Based on this knowledge, the first gene
expression-based clinical endometrial receptivity test was introduced in
2011 (Díaz-Gimeno et al., 2011) and has been successfully applied to
detect the most appropriate day for embryo transfer in women under-
going IVF (Ruiz-Alonso et al., 2013). Yet, while previous endometrial
transcriptome studies, using either microarray or RNA sequencing
(RNA-seq) technology, have identified numerous transcripts differen-
tially expressed during the mid-secretory phase, the overlap between
the reported significantly altered genes among studies has remained
modest and the exact mechanisms of receptivity are still not fully
understood (Gómez et al., 2015).
However, given the phase-dependent changes in tissue cellular com-
position during the menstrual cycle, the gene expression differences
identified in the whole-tissue sample may be partially consequent on
these changes eclipsing the true alterations in expression levels. This
phenomenon is further exaggerated by inter-sample differences in cel-
lular heterogeneity levels, likely due to biological or technical issues,
related to the means used to obtain the tissue biopsy. Therefore, for
studies reporting differential expression, it is unclear whether the
observed changes in transcript levels reflect variations in cellular sub-
populations in the whole-tissue biopsy, altered gene expression in
these subpopulations, or a combination of the two. In support of
this idea, distinct gene expression patterns of the two dominant
endometrial cell types, epithelial and stromal cells, during the WOI
were first shown by a study using laser microdissection microscopy to
separate endometrial glandular epithelial and stromal cells (Evans
et al., 2012), and confirmed by our recent study using transcriptomics
of fluorescence-activated sorted cells (Altmäe et al., 2017). However,
in addition to a costly and time-consuming cell sorting procedure, cell
isolation entails a loss of a more general view on tissue complexity and
may affect both the viability and genome activity of isolated cells
(Hayman et al., 2006; Strell et al., 2018). Although the above-
mentioned issues support the whole-tissue transcriptome analysis,
ignoring the cellular heterogeneity in whole-tissue analysis may cause
misinterpretation of the genomic data, particularly for highly hetero-
genic tissues (Shen-Orr and Gaujoux, 2013). As an alternative to
cell-type isolation techniques, computational decomposition (or
deconvolution) of gene expression profiles from heterogeneous tissue
has been proposed to adjust for differences stemming from variation
in biopsy cellular composition, and has been successfully used for gene
expression profiling of blood, lymphoid and tumour tissues (Li et al.,
2017; Pan et al., 2017; Schelker et al., 2017; Chen et al., 2017b).
In the current study, we utilized a computational approach to esti-
mate cell-type fractions in biopsies and to deconvolute the endomet-
rial whole-tissue gene expression profile. This approach helps to adjust
for expression changes stemming from altered cellular composition of
biopsied samples taken at different phases of the menstrual cycle, and
to reveal the true gene expression changes irrespective of the cellular
heterogeneity of the tissue analysed. The current study is the first using
gene expression profiling adjusted for cellular heterogeneity to
uncover the mechanisms of endometrial receptivity that otherwise
would remain hidden in whole-tissue genomic analysis.
Materials andMethods
The study was approved by the Research Ethics Committee of the
University of Tartu, Estonia (No 221/M-31) and Ethical Clinical Research
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Committee of IVI Clinic, Valencia, Spain (No 1201-C-094-CS). Informed
consent was signed by all women who entered the study.
Study participants
For RNA-seq, the endometrial tissue samples were obtained in Estonia
and Spain from fertile-aged women, with normal body mass index (BMI)
and self-reported regular menstrual cycles (Estonia n = 20, Spain n = 15; a
total of 35 women), who had not received hormonal treatments for at
least three months prior to the time of biopsy. The average age and BMI
were 29.1 ± 3.6 years and 23.2 ± 2.9 kg/m2 for Spanish women, and 30.2
± 3.4 years and 23.2 ± 4.5 kg/m2 for Estonian women, respectively. The
women had at least one live-born child and no previous infertility records.
As it has been shown that endometrial transcriptomic profile is not
affected by a previous biopsy taken in the same menstrual cycle (Miravet
et al., 2017), two endometrial biopsies were obtained using Pipelle cath-
eter (Laboratoire CCD, France) within the same natural menstrual cycle;
the first during the early secretory endometrial phase (ESE; two days after
the luteinizing hormone surge [LH + 2] in Spain and LH + 1 to LH + 3 in
Estonia) and the second sample during the mid-secretory endometrial
phase (MSE; day LH + 7 in Spain and day LH + 7 to LH + 9 in Estonia).
Additionally, 10 paired endometrial samples from healthy women (age
30.1 ± 3.1 years and BMI 24.1 ± 4.8 kg/m2, non-smokers with proven fer-
tility) from Estonia were used for qPCR validation of RNA-seq results.
Endometrial sample timing was confirmed by histological examination
according to Noyes’ criteria (Noyes et al., 1975). The samples were stored
at −80°C until use.
Total RNA extraction from endometrial
tissue
For the total RNA extraction, up to 30 mg of the tissue was homogenized
in the presence of QIAzol reagent (Qiagen, Germany) and mechanical lysis
(0.5 mm diameter steel bead, TissueLyser LT (20–40 s)), and processed
using miRNeasy Mini kit (Qiagen), following the manufacturer’s protocol.
miRNA content was decreased using Qiagen’s MinElute protocol. DNase I
treatment was performed on column using RNase-Free DNase Set
(Qiagen). Purified RNA integrity number (RIN) and quantity were deter-
mined with Bioanalyzer 2100 RNA Nano 6000 kit (Agilent Technologies,
USA).
mRNA sequencing
The endometrial total RNA samples with a concentration at least 200 ng/
μl and RIN >8.0 were used for cDNA synthesis and library construction.
Libraries were generated from 4 μg of total RNA using Illumina TruSeq
Stranded technology (Illumina, USA), following the manufacturer’s proto-
col. Libraries were normalized, pooled and sequenced using HiSeq™
2000/2500 with a configuration of 100 cycles paired-end reads in the
three sample groups: Estonian Est 1 cohort samples at Estonian Genome
Center Core Facility (Tartu, Estonia), Est 2 cohort samples at Institute for
Molecular Medicine Finland (FIMM, Helsinki, Finland) and Spanish samples
at Lifesequencing S.L. (Valencia, Spain).
RNA sequencing analysis and data
preparation
The processing of raw RNA reads, that included quality control, adapter
removing, trimming and mapping to human genome hg19 was performed
as previously described (Altmäe et al., 2017). The RNA-seq data pre-
sented in this study is deposited in the Gene Expression Omnibus database
with accession number GSE98386.
Transcriptome profiling of early secretory
and mid-secretory endometrial samples
To rule out population- and/or batch-specific effects, differential expres-
sion (DE) analysis was carried out separately in three groups according to
sequencing centre: Est 1, Est 2 and Spain. For group-level DE analyses, the
edgeR software was used. Before DE analysis, transcripts with low or
uneven expression patterns were filtered out, retaining transcripts with
counts per million (CPM) ≥2 in at least half of the samples (±5%) for sub-
sequent analysis. We used a paired analysis design, which takes into
account the paired nature of the biopsies collected from each woman and
thus increases statistical power, while at the same time reduces the effect
of potential confounding factors.
Thereafter, results from all three participating groups were meta-
analysed using the METAL tool (Willer et al., 2010) to identify transcripts
that exhibit similar DE patterns in different groups. Genes with consistent
effect direction over three groups with p-value lower than Bonferroni cor-
rected p-value threshold (0.05 divided by the number of transcripts
included in the meta-analysis) were considered statistically significantly dif-
ferentially expressed.
Deconvolution analysis
For the deconvolution of endometrial whole-tissue gene expression pro-
files, single-cell tagged reverse transcription (STRT)-based RNA-seq data
for bulk-RNA from endometrial stromal and epithelial cells was used.
STRT data for both Estonian and Spanish samples was used to deconvolute
the gene expression profiles of samples from respective groups. In totally,
we used pre-analysed RNA-seq data for 19 stromal and 17 epithelial frac-
tions from ESE and 24 stromal and 24 epithelial fractions from MSE. The
detailed information on participants and sampling is presented in our previ-
ous study (Altmäe et al., 2017). Briefly, the cell populations were extracted
by fluorescence-activated cell sorting (FACS) from endometrial biopsies of
healthy women, and analysed using the STRTprep pipeline as previously
described (Krjutškov et al., 2016) (Fig. 1). As the pipeline uses hg19 refer-
ence genome for mapping, and a different version of annotation file for
aligning/counting, only the .bam files from the pipeline were used for fur-
ther steps. The mapped reads were aligned on Ensembl v.75 annotation
file, the same file used for whole-tissue RNA-seq data, and raw counts
were obtained with HTSeq package script htseq-count v.0.6.1 (Anders
et al., 2015). The normalized CPMs were obtained using R package edgeR
v. 3.6.2 (Robinson et al., 2010) and the default normalization function
instead the spike-in normalization.
For deconvolution, we used the R package DeconRNASeq v.1.10.0
(Gong and Szustakowski, 2013), which uses tissue and pure cell-type spe-
cific expression patterns to decompose mixed tissue to cell types. The
package adopts a globally optimized non-negative decomposition algo-
rithm through quadratic programming to estimate cell-type proportions in
the heterogeneous tissue. As the input, it takes normalized expression
levels from pure cell fractions for some set of transcripts and the mixed tis-
sue normalized expression levels. Both the cell fraction-specific and mixed
expression values should be in same units and normalized using the same
method. In this study, normalized CPMs of all non-zero expressed tran-
scripts from stroma and epithelium STRT-sequencing, and from endomet-
rial biopsies were used as the input, and the median value of cell-specific
expression per cell-type over sample group was used to estimate the pro-
portions of stromal and epithelial cells in the heterogenous endometrial tis-
sue (Fig. 1).
The stromal and epithelial cell proportions obtained from deconvolution
for ESE and MSE samples were used in downstream DE analyses. The DE
analyses were done the same way as described above, except this time cell
proportions were used as covariates (Fig. 1). As the stroma and epithelium
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proportions together add up to 1.0, only the stroma proportions were
used as covariates. The meta-analysis for groups was done as described
above.
Correlation between estimated cellular
proportions and histological dating
To test the accuracy of the estimated proportions of stromal and epithelial
cells resulting from deconvolution, we correlated the epithelial fraction
estimates with estimated endometrial cycle day (corresponding to a 28-
day cycle) from histological analysis. For this, we used the histological
evaluation data for 18 paired samples (nine from ESE and nine from MSE
phase) for which detailed dating information was available. If the endomet-
rial cycle date had been given as a range (e.g. days 21–23), the arithmetic
mean was used for calculating the Pearson correlation coefficient.
Additionally, we assessed the proportion of epithelial and stromal tissue in
the two time-points in histological images, and compared the numbers to
those obtained from deconvolution analysis. The histological specimens
were prepared from formalin-fixed paraffin-embedded endometrial tissue
sections using standard hematoxylin and eosin staining protocol (Fischer
et al., 2008). The proportions of epithelial and stromal cells in the speci-
men were robustly calculated by measuring the areas occupied by either
cell type in histological images using Adobe Photoshop CC 2017. The size
of the selected areas was converted to pixels, and the proportion of epi-
thelial cells was calculated by dividing the area under epithelial cells (in pix-
els) to that of the entire specimen. The analysis included a total of 13
specimens (eight ESE and five MSE), since for some individuals, more than
one image was available for evaluation. One to three optical fields were
analysed per each sample and, in case of multiple measurements, the aver-
age proportions were calculated across evaluations.
Figure 1 A simplified overview of the gene expression profile computational deconvolution of endometrial tissue. Endometrial biopsies were homo-
genized and total RNA extracted from whole-tissue samples was sequenced. In parallel, two cell types from endometrial biopsies were separated; epi-
thelial cells were labelled with fluorochrome-conjugated mouse anti-human CD9 monoclonal antibody and stromal cells were simultaneously labelled
with fluorochrome-conjugated mouse anti-human CD13 monoclonal antibody, followed by flow cytometric analysis and FACS cell sorting. Bulk-RNA
full transcriptome analysis of FACS-sorted endometrial epithelial and stromal cells was performed with the RNA-seq method, following the single-cell
tagged reverse transcription (STRT) protocol with modifications. Reference proportions of epithelium (E) and stroma (S) were calculated for each sam-
ple using DeconRNASeq algorithm. By using transcript measures from separate cell-types (FACS-sorted epithelial and stromal cell populations) and
transcript measures from whole-tissue samples, the algorithm estimates the cell-type proportions over samples by fitting a non-negative least squares
equation for each transcript. Further, it calculates the theoretical proportions of epithelium and stroma across the whole transcriptome. The expres-
sion level xjk of gene j in a sample k is the average of expected expression level s across the cell types sij, weighted by the respective cell-type propor-
tions aki (i = 1… N, N: the total number of cell types) (Adapted from (Gong and Szustakowski, 2013)). Average stroma proportions calculated from all
whole-tissue samples used for RNAseq were then applied as covariates in differential expression (DE) analysis using edgeR.
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Functional annotation of differentially
expressed genes
Functional annotation was performed with Ingenuity Pathway Analysis
(IPA) tool using all significant differentially expressed genes (DEGs) identi-
fied after deconvolution. Pathway analysis was performed using IPA with
default settings, and pathways with a Benjamini-Hochberg p-value <0.05
were considered as significantly enriched. Networks of significantly DEGs
were then algorithmically generated based on their connectivity.
Endometrial receptivity markers
To outline potential biomarker candidates that exhibit true expression
change in MSE and could thus be detected by routine transcriptome analysis
of whole-tissue biopsy, meta-analysis DEG lists identified before and after
deconvolution analysis (|log2FC| ≥ 1, outranked Bonferroni p-value) were
compared and overlapping transcripts were selected as marker candidates.
Further, our marker candidate list was compared with DEG lists
reported in previous RNA-seq and microarray studies on human endo-
metrium (Carson et al., 2002; Kao et al., 2002; Borthwick et al., 2003;
Riesewijk et al., 2003; Mirkin et al., 2005; Talbi et al., 2006; Altmäe et al.,
2010; Tseng et al., 2010; Díaz-Gimeno et al., 2011; Hu et al., 2014;
Sigurgeirsson et al., 2016). Genes previously identified as differentially
expressed between MSE and ESE were referred to as ‘known marker can-
didates’, including transcriptomic markers commonly used in endometrial
testing (Díaz-Gimeno et al., 2011; Enciso et al., 2018), and others were
recognized as ‘novel’.
In addition, the list of transcripts, significant in the unadjusted transcrip-
tome and non-significant after deconvolution, were compared with gene
expression profiles of isolated epithelial and stromal cells, obtained from
STRT RNA-seq (original data in Altmäe et al., 2017). Genes that exhibited
no significant expression change on the cell-population level were con-
sidered as genes whose expression change in whole tissue is derived from
cell-type proportion fluctuations.
Quantitative real-time PCR analysis
For technical validation of the results, reverse transcriptase quantitative
PCR (RT-qPCR) was applied on selected endometrial marker candidates,
using ten paired ESE and MSE total RNA samples from healthy volunteers
different from these used in the RNA-seq study. The selection criteria for
RT-qPCR validation were expression change |log2FC| ≥ 1.5 in all groups
and read count log2CPM ≥ 4, based on our previous expertise.
For RT-qPCR, 1 μg of total RNA was reverse-transcribed using random
hexamer primer (Thermo Scientific, USA) and cDNA was amplified and
quantified using 7500 Fast Real-Time PCR System (Applied Biosystems,
USA), using HOT FIREPol EvaGreen qPCR Mix Plus (Solis BioDyne,
Estonia) and 250 nM of sense and antisense primers specific for nucleotide
sequence of selected marker candidates or housekeeping genes, TBP and
SDHA. Data were analysed using 7500 Software v2.0.5 (Applied
Biosystems). Differences in gene expression levels were estimated using
comparative Ct (2−ΔΔCt) method (Livak and Schmittgen, 2001). The
Wilcoxon paired sample test was applied to estimate significance level.
The oligonucleotide primers are presented in Supplementary Table S1.
Results
Differential expression analysis between mid-
secretory and early secretory endometrium
In the present study, we used RNA-seq to analyse gene expression of
endometrial samples; 70 individual cDNA libraries (35 ESE and 35 MSE
samples) were sequenced and an average of 54 million read pairs were
generated per library. The summary of RNA-seq results are provided
in Supplementary Table SII. After filtering out low-quality reads from
the datasets, an average of approximately 90% of the qualified read
pairs across all groups were mapped to human genome version 19. A
schematic overview of the analysis and results is presented in Fig. 2.
The total number of expressed transcripts ranged from 21,890 to
30,576 per studied sample (Supplementary Table SII). DEGs within
three groups were detected using paired sample design, followed by
meta-analysis of all expressed genes with METAL software. This
resulted in total of 3591 genes (1800 up-regulated and 1791 down-
regulated) that were identified as statistically significantly differentially
expressed in MSE (Bonferroni p-value <2.79 × 10−6) and showed the
same direction in expression change in all three groups, as presented
in Supplementary Table SIII. The average logarithmic expression fold
change (Log2FC) of genes expressed in MSE ranged between 5.3 and
8.8 in both directions (Supplementary Table SIII). The genes with the
highest expression rate change were PAEP, C4BPA, C2CD4A, CXCL14,
GPX3, SLC15A1, MT1G, HAP1, MFSD4A and IRX3. The most signifi-
cantly differentially expressed genes were SLC15A1, SLC1A1, SNX10,
DKK1, GADD45A, AOX1, GPX3, DPP4, HEY2 andMYOCD.
Expression profile deconvolution of
endometrial tissue
To clarify whether the observed changes in gene expression levels
might actually stem from fluctuations in biopsy cellular composition,
we used gene expression data for isolated endometrial epithelial and
stromal cells to perform endometrial whole-tissue gene expression
profile deconvolution. As a first step of the analysis, gene expression
profiles of homogenous cell populations derived from ESE and MSE
were compared with whole-tissue transcriptomes to estimate the rela-
tive proportions of these cellular subpopulations in the whole-tissue
biopsy. This analysis revealed that the stromal fraction was larger in
ESE biopsies, while in MSE biopsies the epithelial fraction was slightly
larger, with considerable inter-individual variation (Fig. 3A). On aver-
age, ESE samples consisted of 65% stromal cells, while the average
stromal fraction in MSE samples was 46%. We observed a good cor-
relation between gene-expression-estimated epithelial cell propor-
tions and endometrial cycle date according to histological evaluation
(r = 0.88 (95% CI 0.71–0.96), P = 1.1 × 10−6), confirming that epithe-
lial fraction becomes more dominant as the cycle progresses (Fig. 3B).
As a second step, the epithelial and stromal cells’ proportions esti-
mated by computational analysis of gene expression profiles were fur-
ther validated by direct histological evaluation using endometrial tissue
samples (Fig. 3C). The histology results suggested that the proportion
of epithelial cells in ESE is around 30%, increasing to approximately
50% by the time of WOI, and this complies with the proportions cal-
culated based on cell-type specific gene expression (35% and 54% for
epithelial cells, respectively) (Fig. 3D).
Transcripts differentially expressed in
mid-secretory endometrium
The proportions obtained from deconvolution were then used as
cofactors in differential expression analysis to account for differences
in cellular composition. After meta-analysis of deconvoluted gene
expression profiles from different groups, 1211 (679 up- and 532
down-regulated) transcripts showed significant expression change in
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MSE endometrium, with Log2FC range between −5.3 and 7.9
(Supplementary Table S4). The genes with the highest expression rate
change were PAEP, HAP1, GPX3, CXCL14, C4BPA, SLC15A1, IRX3,
MMP26, C2CD4A and SULT1C2P. The most significantly differentially
expressed genes were SLC15A1, SLC1A1, SNX10, DKK1, GADD45A,
AOX1, GPX3, DPP4, HEY2 andMYOCD.
As a result of RT-qPCR-based validation, MYOCD, LINC01320,
SLC8A1, TRPC4 and GGATP1 showed significant expression rate change
in MSE samples (Fig. 4).
Further, all 1211 transcripts that exhibited significant expression
change in MSE after adjusting for differences in cellular composition
were subject to functional annotation in order to investigate their role
in endometrial maturation processes. DE genes with the highest signifi-
cance level (n = 90) and expression fold change (n = 90) are depicted
in Fig. 5 (Supplementary Table SIV).
Pathway mapping with IPA indicated that WOI DEGs are involved
in many basic cellular functions and processes and, in particular, cell
fate, cellular movement, cell-to-cell signalling, cellular growth and
development, inflammatory and vascular development processes
(Supplementary Table SV). In total, the IPA tool identified 25 Ingenuity
Knowledge Database pathways significantly enriched in the MSE tran-
scriptome relative to ESE (Benjamini-Hochberg FDR< 0.05), highlight-
ing the major regulative role of NFkB (Supplementary Figure S1A),
interferon α (Supplementary Figure S1B), steroid hormone activity
(Supplementary Figure S1C) and MAPK/ERK signalling (Supplementary
Figure S1D–F) in human endometrium. All molecular interaction net-
works with a score at least 21 (Krämer et al., 2014) are presented in
Supplementary Figure S1A–K.
Marker candidate genes for endometrial
receptivity
When significant DEG lists before (3591 transcripts) and after (1211)
deconvolution analysis were compared, 946 transcripts came out sig-
nificant in both approaches (Fig. 6, Supplementary Tables SIII and SIV)
and therefore were considered as genes with the true expression
change in MSE compared to ESE. There were 2645 transcripts, which
are almost 74% from all DE transcripts identified without deconvolu-
tion, not considered significantly differentially expressed after adjust-
ment for tissue cellular composition (Fig. 6; Supplementary Table SIII).
Of these, the genes with the highest expression change between MSE
and ESE in whole tissue (Log2FC > 3), yet not differentially expressed
after deconvolution, are presented in the Table I. Moreover, 265 tran-
scripts came out significant only after deconvolution was applied
(Fig. 6; Supplementary Table SIV).
Further, we compared our results with those from eleven publica-
tions that have reported genes differentially expressed during WOI in
healthy women, including nine microarray (Carson et al., 2002; Kao
Figure 2 Overview of the endometrial RNA-seq data analysis pipeline and results. Sequenced endometrial total RNA samples were processed using
two parallel approaches: (i) differential expression analysis followed by meta-analysis of results from different groups and (ii) deconvolution followed by
DE and meta-analysis. Functional analysis was performed on all significant genes using the deconvolution-based approach. Significant transcripts identi-
fied by the two approaches were compared resulting in a set of common transcripts. ESE—early secretory endometrium; MSE—mid-secretory endo-
metrium; N—number of analysed samples; n—numbers of DE transcripts identified during each step of the analysis; DE—differential expression;
Consensus genes—genes reported in 11 selected receptivity-related microarray and RNA-seq studies (please, see main text for the references).
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et al., 2002; Borthwick et al., 2003; Riesewijk et al., 2003; Mirkin et al.,
2005; Talbi et al., 2006; Altmäe et al., 2010; Tseng et al., 2010;
Díaz-Gimeno et al., 2011) and two RNA-seq studies (Hu et al., 2014;
Sigurgeirsson et al., 2016). Publications were selected based on the
availability and quality of gene expression datasets. As a result, 171
transcripts overlapped among both microarray and RNA-seq studies
(Supplementary Table SVIA), 526 transcripts were found in either
microarray or RNA-seq study, while 249 transcripts were recognized
as novel or previously not reported in endometrial WOI-related tran-
scriptome (Supplementary Table SVIB). The top significant novel tran-
scripts are presented in the Table II.
In addition to protein coding genes, possible regulatory transcripts,
e.g. non-coding RNAs, were identified. The list of significant DE long
intergenic non-coding RNAs (lincRNAs) is presented in Table III.
Discussion
One of the main objectives of our study was to investigate how histo-
logical changes during the menstrual cycle affect the detection of gene
expression profiles of heterogeneous endometrial tissue. While the
histological changes that distinguish MSE from ESE are well described
(Noyes et al., 1975; Crum et al., 2003), to the best of our knowledge,
we are the first to show how epithelial and stromal fractions are actu-
ally altered between the pre-receptive and receptive state, by using a
computational deconvolution approach.
The morphological criteria used for endometrial dating have major
limitations for predicting endometrial receptivity (Coutifaris et al., 2004;
Murray et al., 2004), therefore endometrial gene expression analysis has
become the new golden standard to predict the WOI. Since
Figure 3 Tissue deconvolution results. A. Proportions of epithelial cells in endometrial biopsies estimated by the computational deconvolution
approach. ESE—early secretory samples. MSE—mid-secretory endometrial samples. B. Correlation between gene expression-estimated proportion
of epithelial cells and menstrual cycle day predicted using Noyes’ criteria for endometrial histological dating. Black dots—ESE samples, red dots—MSE
samples, according to urine LH test. C. Histological slide image of ESE and MSE samples, used for endometrial epithelial and stromal proportions’
counting. The samples were prepared from formalin-fixed paraffin-embedded endometrial tissue sections using standard hematoxylin and eosin stain-
ing protocol. E—epithelium and S—stroma. D. Comparison between epithelial cell proportions estimated using two different approaches: histological
evaluation of epithelial fraction (dark grey) and proportions calculated based on cell-type specific gene expression patterns (light grey). In five out of six
samples the proportions calculated by both methods were comparable.
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endometrial biopsies contain a range of cell types in varying proportions,
due to both biological and technical reasons, some of the observed
changes in gene expression levels might actually stem from differences in
biopsy cellular composition. Although this issue has been discussed
before (Edgell et al., 2013; Altmäe et al., 2014), it has never been experi-
mentally addressed in previous endometrial transcriptome studies. As a
substantial improvement compared to previous endometrial gene
expression studies, we applied gene expression profile deconvolution to
account for biopsy cellular composition that could artificially alter the
observed expression profile of a whole-tissue biopsy. Only 26% of the
transcripts identified by meta-analysis without prior adjustment for cellu-
lar heterogeneity remained significant after deconvolution analysis was
applied (Fig. 6, Supplementary Table SIII and SIV), while the remaining
74% rather reflect the variation in tissue cellular composition between
the two compared time points. Among the latter category are much
studied receptivity-associated genes: CLDN4, FOS, CCND2, AR, VC,
CXCL13, PENK, OPRK1, KIF4A, POSTN, OLFM4, PRC1, KMO, AMIGO2,
ECM1, RASSF2, KIF20A and LRP4 (Díaz-Gimeno et al., 2011; Altmäe
et al., 2017). For example, olfactomedin 4 (OLFM4; Table I) has been
shown to be significantly down-regulated in MSE samples (Díaz-Gimeno
et al., 2011) but shows no significant expression change between MSE
and ESE in either epithelial or stromal cells when evaluated separately
(Dassen et al., 2010; Kodithuwakku et al., 2011).
Further, we described DE transcripts that were significantly differen-
tially expressed only after deconvolution analysis was applied, but
were non-significant before deconvolution (n = 265, Fig. 6). The
expression change of these genes in whole-tissue biopsy may be
eclipsed by fluctuations in cell-type proportions in endometrial biop-
sies, potentially leading to underestimation of processes and pathways
involved in endometrial maturation. Among these transcripts we found
genes that have not been previously reported to be related to WOI.
For example, cell migration-associated protein GLIPR2 and fibroblast
growth factor 2 (FGF2) are believed to be involved in extracellular
signal-regulated kinase (ERK) signalling (Paiva et al., 2011; Huang et al.,
2013), one of the key pathways in endometrial gene expression regula-
tion (Supplementary Table SV; Figure S1D) (Fluhr et al., 2013).
Inflammatory response-associated gap-junction alpha-1 (GJA1)
(Supplementary Figure S1D), also found significantly differentially
expressed only after deconvolution analysis, is differentially expressed
in stromal cells during MSE, and promotes stromal cell differentiation
and maintenance of the decidualized endometrial phenotype (Yu et al.,
2011, 2014). Although, to the best of our knowledge, these genes
have not yet been reported in human MSE transcriptome studies pre-
viously, their aberrant expression has been shown in endometrial stud-
ies focusing on implantation failure and insufficient endometrial growth
(Tapia et al., 2008; Maekawa et al., 2017), supporting their involve-
ment in endometrial processes. It is important to outline that in our
study these genes did not show significant expression change in whole-
tissue samples, suggesting that dynamic epithelial and stromal cell pro-
portions may also be the reason they have not been reported before
in whole-tissue transcriptomic studies.
Our information about endometrial receptivity-associated gene
expression keeps improving. Thousands of genes have been suggested
to take part in the processes of endometrial maturation, with respect
to their WOI-marker potential. Previous findings summarized in two
recent publications have outlined that the WOI could be characterized
by a relatively small number of differentially expressed genes (Altmäe
et al., 2017; Enciso et al., 2018). In the present study, we also report a
set of 1211 transcripts differentially expressed between MSE and ESE
after deconvolution (Supplementary Table SIV). Figure 5 summarizes
Figure 4 RT-qPCR validation of five marker candidates, using ten paired early secretory (ESE) and mid-secretory (MSE) endometrial samples. The
dots connected with a solid line represent samples from the same patient. Significant: paired Wilcoxon test P-value <0.01.
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the set of transcripts, significantly differentially expressed in MSE after
endometrial gene expression profile was adjusted for epithelial and
stromal fractions, by extracting the transcripts with the highest expres-
sion rate change (outer gene circle, n = 90) and significance level (inner
gene circle, n = 90). These top genes were also among the 946 poten-
tial endometrial receptivity markers that exhibited significant expres-
sion change in whole-tissue transcriptome analysis. Moreover, 31
genes (C4BPA, CD55, DPP4, AOX1, LMCD1, PLCH1, FRAS1, BMPR1B,
SH3RF2, GPX3, SOD2, CYP2A5, SNX10, PRR15, SLC1A1, PAEP, DKK1,
HABP2, DLG2, NNMT, TRPC4, SLC15A1, NPAS3, FGF7, C2CD4A, IRX3,
MYOCD, PAK5, POM121L9, MAOA and GRIA3) were located in both
circles, which suggests their great biomarker potential. Twelve of these
genes, PAEP, GPX3, C4BPA, DPP4, DKK1, CD55, NNMT, MAOA,
HABP2, SOD2, AOX1 and SLC1A1, are already applied endometrial
receptivity markers (Díaz-Gimeno et al., 2011; Altmäe et al., 2017;
Enciso et al., 2018), while others have been previously reported in
endometrial receptivity-related transcriptome studies (Altmäe et al.,
2012; Hu et al., 2014; Sigurgeirsson et al., 2016; Chen et al., 2017a).
Still, many of the genes identified in our study (Supplementary
Table SIV) have not been reported in MSE transcriptome studies
before. For example, solute carrier family member, SLC8A1, one of the
top differentially expressed genes, is recruited in ERK1/2 activation
and can modulate immunoglobulin-mediated immune response
through ERK1/2 or through interaction with major histocompatibility
complex (MHC) class I proteins (Supplementary Table SV and SVIB,
Supplementary Figure S1 D).
Our results also support the previously discussed important role of
immune responses in the pre- and peri-implantation period (Altmäe
et al., 2010; Gnainsky et al., 2014; Haller-Kikkatalo et al., 2014; Altmäe
et al., 2017). For example, type I interferon-activated proteins caspase
1 (CASP1), tumour suppressor protein SAMD9L and phospholipid
scramblase 1 (PLSCR1) induce the innate immune response and pro-
mote endometrial antiviral status (Catalano et al., 2007; Boon et al.,
2014; Wang et al., 2016) (Supplementary Figure SVI B). We also noted
Figure 5 Differentially expressed genes (DEGs) between early secretory (ESE) and mid-secretory (MSE) endometrial samples. Scatterplot repre-
sents DEGs significant after deconvolution (Bonferroni P-value <2.79 × 10−6). Numbers represent chromosomes. The inner circle gene names contain
top significant DEGs (red—up-regulated and blue—down-regulated in MSE, respectively), while the outer circle contains DEGs with the highest
expression rate fold change between ESE and MSE (pink—up-regulated and green—down-regulated in MSE, respectively).
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that the expression change of these three genes in MSE before decon-
volution was under 2-fold (Supplementary Table SIII), which may be
the reason why these genes have never been reported in studies using
at least a 2-fold expression change threshold. The 171 DE genes, over-
lapping between our results and previously published RNA-seq and
array studies, can be considered as genes with the highest endometrial
receptivity marker potential, while novel marker candidates reported
in our study need further investigation in order to understand how
they are involved in endometrial maturation (Supplementary Table SVI
A and B). It is also interesting that 126 of 238 initial endometrial recep-
tivity array (ERA) genes (Díaz-Gimeno et al., 2011) exhibited significant
expression change after adjustment for biopsy cellular composition,
while for the remaining 112 ERA genes, the expression changes may
arise from uneven cellular content in biopsies or from the dramatic
transcriptional changes in minor cell types not analysed in our study
(e.g. immune cells).
With the implementation of transcriptomic tools in endometrial
analysis, it has become clear that not only protein coding genes are
important for endometrial receptivity. LincRNAs have significant regu-
lative potential on transcriptional and translational levels through direct
interactions with different types of RNAs and proteins (Kung et al.,
2013; Groen et al., 2014). Recently, Sigurgeirsson and colleagues
showed the potential role of lincRNAs in endometrial receptivity
(Sigurgeirsson et al., 2016). We report eight lincRNAs significantly up-
or down-regulated in MSE (Table III). Our results demonstrate that
LINC01320 in particular has a strong effect in all studied groups
(Table II, Supplementary Table SIII and SIV), confirmed by RT-qPCR
(Fig. 4). Previously, differential expression of LINC01320 was reported
in endometrial and ovarian cancer cells (Chen et al., 2017a), although,
to the best of our knowledge, it has never been associated with endo-
metrial receptivity before.
Certain limitations of our study also need to be acknowledged. For
gene expression profile deconvolution, only stromal and epithelial cell
fractions were considered, whereas other cells, such as endothelial
and immune cells, or even cell types we may not be aware of, also
could contribute to the gene expression profile. Although there is no
available data on gene expression profiles of minor endometrial cell
types, the failure to consider their expression changes may provide
slightly biased results. Second, using actual counts for cellular subpopu-
lations obtained by FACS as covariates in differential expression ana-
lysis is likely to provide more accurate expression change estimates
than the computational deconvolution applied in this study.
Figure 6 Numbers of significantly differentially expressed tran-
scripts identified from meta-analysis of transcriptomic profiles of
endometrial tissue samples from different groups. A. Transcripts iden-
tified in whole endometrial tissue (before deconvolution, BD; n =
3591). B. Transcripts identified in cellular heterogeneity-adjusted
expression profiles (after deconvolution, AD; n = 1211). C.
Transcripts significant only in whole-tissue transcriptome and non-
significant after deconvolution (blue, n = 2645) were considered
genes whose expression change in whole-tissue may be derived from
variation in cell types’ proportions. D. Differentially expressed tran-
scripts significant only after tissue deconvolution (pink, n = 265) were
considered genes whose expression change may be eclipsed in mid-
secretory endometrium due to fluctuations in cell-type proportions,
leading to underestimation of molecular processes and pathways
involved in endometrial maturation. E. Transcripts significant in both
approaches (purple, n = 946) are considered potential WOI markers.
.............................................................................................................................................................................................
Table I Top significantly differentially expressed genes in endometrial whole-tissue samples, that remained sub-
significant after deconvolution analysis. FC - average expression fold change between mid-secretory and early secretory
samples. P-value—Bonferroni P-value. BD—before deconvolution.
Gene symbol Gene name FC BD P-value BD
OLFM4 Olfactomedin 4 −15.8 9.02E−33
LEFTY1 Left-right determination factor 1 13.35 6.02E−35
LHFPL3 LHFPL tetraspan subfamily member 3 14.04 1.04E−30
BRINP1 BMP/retinoic acid inducible neural specific 1 12.58 4.87E−23
POSTN Periostin −12.48 5.11E−39
SLC47A1 Solute carrier family 47 member 1 −11.87 7.01E−44
FGF1 Fibroblast growth factor 1 −10.97 2.13E−49
GABRA3 Gamma-aminobutyric acid type A receptor alpha3 subunit −9.52 1.83E−52
COL17A1 Collagen type XVII alpha-1 chain 8.9 4.96E−30
TMEM154 Transmembrane protein 154 8.68 2.42E−40
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Nonetheless, computational deconvolution is becoming increasingly
popular (Reinartz et al., 2016; Scott et al., 2016; Yu and He, 2017),
and has been shown to have accuracy similar to methods using actual
cell counts (Newman et al., 2015). As a marked methodological
improvement, we addressed the transcriptomic changes in human
endometrium using meta-analysis of samples from different popula-
tions, which not only helps to further eliminate population-specific and
batch effects, but also to gain the statistical power required. As a
result, we suggest a set of robust endometrial receptivity markers that
reflect actual expression changes that take place in endometrial tissue,
irrespective of its cellular composition. However, novel potential
endometrial transcriptomic markers identified in our study, such as
LINC01320, need further investigation to elucidate their role in endo-
metrial functioning.
In conclusion, our results show how the proportions of endometrial
epithelial and stromal cells change in endometrial biopsies during the
transition from the pre-receptive to receptive state and demonstrate
how these changes affect the gene expression profile of biopsied tis-
sue. Overall, our results highlight that the cellular composition of
biopsies must be taken into consideration in endometrial ‘omics’ stud-
ies where whole-tissue samples are involved.
Supplementary data
Supplementary data are available at Human Reproduction online.
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